These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25573829)

  • 1. Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS Study.
    Metra M; Cotter G; El-Khorazaty J; Davison BA; Milo O; Carubelli V; Bourge RC; Cleland JG; Jondeau G; Krum H; O'Connor CM; Parker JD; Torre-Amione G; van Veldhuisen DJ; Rainisio M; Kobrin I; McMurray JJ; Teerlink JR
    J Card Fail; 2015 Mar; 21(3):179-88. PubMed ID: 25573829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in the management and outcome of atrial fibrillation complicating acute heart failure.
    Gevaert SA; de Bacquer D; Willems AM; Vande Kerckhove B; Weytjens C; van Camp G; de Sutter J
    J Card Fail; 2014 Jun; 20(6):431-7. PubMed ID: 24650634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial.
    Metra M; Mentz RJ; Chiswell K; Bloomfield DM; Cleland JG; Cotter G; Davison BA; Dittrich HC; Fiuzat M; Givertz MM; Lazzarini V; Mansoor GA; Massie BM; Ponikowski P; Teerlink JR; Voors AA; O'Connor CM
    Eur J Heart Fail; 2015 Jan; 17(1):109-18. PubMed ID: 25431336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
    Mentz RJ; Chung MJ; Gheorghiade M; Pang PS; Kwasny MJ; Ambrosy AP; Vaduganathan M; O'Connor CM; Swedberg K; Zannad F; Konstam MA; Maggioni AP
    Am Heart J; 2012 Dec; 164(6):884-92.e2. PubMed ID: 23194489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study.
    Cotter G; Metra M; Davison BA; Senger S; Bourge RC; Cleland JG; Jondeau G; Krum H; O'Connor CM; Parker JD; Torre-Amione G; van Veldhuisen DJ; Milo O; Kobrin I; Rainisio M; McMurray JJ; Teerlink JR;
    Eur J Heart Fail; 2014 Dec; 16(12):1362-71. PubMed ID: 25371147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study.
    van Deursen VM; Edwards C; Cotter G; Davison BA; Damman K; Teerlink JR; Metra M; Felker GM; Ponikowski P; Unemori E; Severin T; Voors AA
    J Card Fail; 2014 Jun; 20(6):407-13. PubMed ID: 24642379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Six-Month Mortality in BNP-Matched Acute Heart Failure Patients.
    Lourenço P; Ribeiro A; Pintalhão M; Silva S; Bettencourt P
    Am J Cardiol; 2015 Sep; 116(5):744-8. PubMed ID: 26115901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups.
    Mogensen UM; Ersbøll M; Andersen M; Andersson C; Hassager C; Torp-Pedersen C; Gustafsson F; Køber L
    Eur J Heart Fail; 2011 Nov; 13(11):1216-23. PubMed ID: 21896536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of low body temperature and poor outcomes in patients admitted with worsening heart failure: a substudy of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial.
    Payvar S; Spertus JA; Miller AB; Casscells SW; Pang PS; Zannad F; Swedberg K; Maggioni AP; Reid KJ; Gheorghiade M;
    Eur J Heart Fail; 2013 Dec; 15(12):1382-9. PubMed ID: 23858000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
    Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and predictors of in-hospital mortality in 270 consecutive patients hospitalised due to acute heart failure in a single cardiology centre during one year.
    Biegus J; Zymliński R; Szachniewicz J; Siwołowski P; Pawluś A; Banasiak W; Jankowska EA; Ponikowski P
    Kardiol Pol; 2011; 69(10):997-1005. PubMed ID: 22006596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).
    Greene SJ; Vaduganathan M; Lupi L; Ambrosy AP; Mentz RJ; Konstam MA; Nodari S; Subacius HP; Fonarow GC; Bonow RO; Gheorghiade M;
    Am J Cardiol; 2013 Feb; 111(4):574-81. PubMed ID: 23206923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF.
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Pieper K; Sun JL; Yancy CW; Young JB;
    Arch Intern Med; 2008 Apr; 168(8):847-54. PubMed ID: 18443260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of serum albumin and serum total cholesterol in the prediction of hospital death in older patients with severe, acute heart failure.
    Arques S; Roux E; Stolidi P; Gelisse R; Ambrosi P
    Arch Cardiovasc Dis; 2011 Oct; 104(10):502-8. PubMed ID: 22044702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acutely decompensated heart failure: characteristics of hospitalized patients and opportunities to improve their care.
    Sarmento PM; Fonseca C; Marques F; Ceia F; Aleixo A
    Rev Port Cardiol; 2006 Jan; 25(1):13-27. PubMed ID: 16623353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Israel Nationwide Heart Failure Survey: Sex differences in early and late mortality for hospitalized heart failure patients.
    Klempfner R; Koifman E; Goldenberg I; Hamdan A; Tofler GH; Kopel E
    J Card Fail; 2014 Mar; 20(3):193-8. PubMed ID: 24374113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and outcomes of very elderly patients after first hospitalization for heart failure.
    Shah RU; Tsai V; Klein L; Heidenreich PA
    Circ Heart Fail; 2011 May; 4(3):301-7. PubMed ID: 21467294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of hospitalization for heart failure and of all-cause mortality after atrioventricular nodal ablation and right ventricular pacing for atrial fibrillation.
    Björkenheim A; Brandes A; Andersson T; Magnuson A; Edvardsson N; Wandt B; Sloth Pedersen H; Poçi D
    Europace; 2014 Dec; 16(12):1772-8. PubMed ID: 25031234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.
    Swedberg K; Olsson LG; Charlesworth A; Cleland J; Hanrath P; Komajda M; Metra M; Torp-Pedersen C; Poole-Wilson P
    Eur Heart J; 2005 Jul; 26(13):1303-8. PubMed ID: 15767288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.